|
|
|
Insider
Information: |
Stanker James H |
Relationship: |
|
City: |
Sykesville |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
54,600 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$8,835 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
54,600 |
|
|
Total
Value |
$8,835 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
GSE Systems Inc |
GVP |
Director |
2019-06-11 |
48,118 |
2016-12-08 |
0 |
Premium* |
|
Processa Pharmaceuticals, Inc. |
PCSA |
|
2024-07-10 |
6,482 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PCSA |
Processa Pharmaceuticals,... |
Chief Financial OfficerOfficer |
|
2020-10-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
41,248 |
|
- |
|
GVP |
GSE Systems Inc |
Director |
|
2016-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,616 |
5,616 |
0 |
- |
|
GVP |
GSE Systems Inc |
Director |
|
2017-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
9,275 |
14,891 |
0 |
- |
|
GVP |
GSE Systems Inc |
Director |
|
2018-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,911 |
22,802 |
0 |
- |
|
GVP |
GSE Systems Inc |
Director |
|
2019-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
25,316 |
48,118 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
|
2020-10-01 |
4 |
B |
$2.10 |
$12,600 |
D/D |
6,000 |
47,248 |
2.74 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
|
2021-06-21 |
4 |
B |
$6.81 |
$6,810 |
D/D |
1,000 |
36,510 |
2.74 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
|
2021-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,601 |
44,111 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
|
2022-08-05 |
4 |
D |
$3.17 |
$7,805 |
D/D |
(2,462) |
49,250 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
|
2022-08-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,601 |
51,712 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
|
2023-02-09 |
4 |
A |
$0.80 |
$10,000 |
D/D |
12,500 |
61,750 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
|
2023-10-10 |
4 |
A |
$0.24 |
$5,400 |
D/D |
22,500 |
84,250 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
|
2023-10-12 |
4 |
A |
$0.33 |
$4,950 |
D/D |
15,000 |
99,250 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
|
2024-01-01 |
4 |
D |
$2.79 |
$1,445 |
D/D |
(518) |
6,120 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
|
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,675 |
6,638 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
|
2024-04-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,675 |
6,638 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
|
2024-04-05 |
4 |
D |
$2.79 |
$1,445 |
D/D |
(518) |
6,120 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
|
2024-07-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
644 |
6,764 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
|
2024-07-10 |
4 |
D |
$1.71 |
$482 |
D/D |
(282) |
6,482 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|